A detailed history of Neville Rodie & Shaw Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 45,460 shares of BSX stock, worth $4.68 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
45,460
Previous 23,205 95.91%
Holding current value
$4.68 Million
Previous $2.34 Million 108.59%
% of portfolio
0.36%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 01, 2025

BUY
$89.7 - $107.41 $2 Million - $2.39 Million
22,255 Added 95.91%
45,460 $4.88 Million
Q1 2025

Apr 01, 2025

BUY
$89.38 - $106.18 $2.07 Million - $2.46 Million
23,205 New
23,205 $2.34 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.